Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Arthur

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 11, 2021
Characteristics and in-hospital outcomes of patients requiring aeromedical retrieval for pregnancy, compared to non-retrieved metropolitan cohortsFergus W Gardiner, Alice Richardson, Carly Roxburgh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Blood|August 14, 2020
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphomaPier Luigi Zinzani, Ian W Flinn, Sam L S Yuen, et al.
Science (New York, N.Y.)|April 2, 2026
Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress responseLucas C Reineke, Ping Jun Zhu, Udit Dalwadi, et al.
Blood|June 24, 2004
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabineKenneth F Bradstock, Jane P Matthews, Raymond M Lowenthal, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Harnessing the Evolution of Proteostasis Networks to Reverse Cognitive DysfunctionLucas C Reineke, Ping Jun Zhu, Udit Dalwadi, et al.
Cell Reports|July 21, 2017
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic SyndromesAshwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 11, 2021
Characteristics and in-hospital outcomes of patients requiring aeromedical retrieval for pregnancy, compared to non-retrieved metropolitan cohortsFergus W Gardiner, Alice Richardson, Carly Roxburgh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Blood|August 14, 2020
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphomaPier Luigi Zinzani, Ian W Flinn, Sam L S Yuen, et al.
Science (New York, N.Y.)|April 2, 2026
Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress responseLucas C Reineke, Ping Jun Zhu, Udit Dalwadi, et al.
Blood|June 24, 2004
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabineKenneth F Bradstock, Jane P Matthews, Raymond M Lowenthal, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Harnessing the Evolution of Proteostasis Networks to Reverse Cognitive DysfunctionLucas C Reineke, Ping Jun Zhu, Udit Dalwadi, et al.
Cell Reports|July 21, 2017
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic SyndromesAshwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck, et al.
Pageof 3